Omnipod无管泵系统背后的公司表示，Ashley McEvoy将接任总裁兼首席执行官，立即生效。 McEvoy取代了吉姆·霍林斯黑德（Jim Hollingshead），后者自2022年6月以来一直在领导该公司。

Insulet解释说，董事会和Hollingshead“相互同意，现在是实施这一领导力过渡的正确时机。”它补充说，Hollingshead已获得咨询合同，以帮助平滑转换。 

主席蒂莫西·斯坎内尔（Timothy Scannell）说，该公司“进行了托洛gh search to identify a dynamic executive with a sophisticated understanding of the MedTech market and a passion for improving lives" before choosing McEvoy, who previously had served as an executive with Johnson & Johnson (JNJ).

The news appears to have offset Insulet's positive update on its outlook. The company reported that it "expects to exceed its previously provided first quarter revenue guidance and intends to raise guidance for the full year." In its fourth quarter和2024年的财务报告，Insulet预测当前季度的收入增长了22％至25％，并且该公司计划于5月8日发布16％至20％。